Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

NCT00909766 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: BMS-830216
DRUG: BMS-830216
DRUG: BMS-830216
DRUG: BMS-830216
DRUG: BMS-830216
DRUG: BMS-830216
DRUG: Placebo

Sponsor

Bristol-Myers Squibb